
A groundbreaking study reveals that consuming two to three cups of coffee daily significantly reduces the risk of…

The FDA granted a groundbreaking Breakthrough Device Designation to Valar Labs’ Vesta, an AI tool that revolutionizes bladder…

Efgartigimod IV, poised for FDA review, offers a promising new option for myasthenia gravis patients, marking a shift…

The DO-HEALTH trial reveals that a combination of omega-3, vitamin D, and strength training slows biological aging in…

Eli Lilly’s Foundayo, the first GLP-1 oral pill without intake restrictions, heralds a new era in weight-loss pharmacotherapy.

A groundbreaking phase 1 clinical trial of a CD40 agonist cancer therapy has demonstrated a 50% response rate,…

A recent study of UK Biobank participants reveals that small daily adjustments in sleep, exercise, and diet can…

A groundbreaking study reveals that obesity drives different disease risks in men and women, urging a shift in…

Groundbreaking research unveils how gut bacteria metabolites like TMAO directly contribute to cardiovascular plaque, signaling a potential shift…

The American Heart Association’s 2026 statistics highlight alarming trends in cardiovascular health, revealing that 122 million US adults…